Multiple myeloma in a patient with prior splenic lymphoma
Keywords:
MULTIPLE MYELOMA, NEOPLASMS, SECOND PRIMARY, SPLENIC NEOPLASMSAbstract
Splenic marginal zone lymphoma is a mature B-cell neoplasm, as multiple myeloma; however, the coexistence of these two entities in the same patient is rare. We present the case of an 82-year-old older adult male with a history of prostatic hyperplasia and arterial hypertension, who at the time of consultation presented general syndrome, fever, abdominal discomfort, hypocolored mucous membranes and palpable spleen tip, without peripheral lymphadenopathy. After performing the paraclinical examinations and according to the result of the spleen biopsy, a splenic marginal zone lymphoma was diagnosed, with no clinical or laboratory evidence of multiple myeloma or Waldestrom's disease. Splenectomy was performed. Subsequently, the patient received six cycles of chemotherapy. He evolved favorably, the symptoms disappeared, the altered complementary symptoms returned to normal and it was decided to continue consultations according to protocol. After four years, in a follow-up consultation, he reported severe bone pain, especially at the level of spine and hips, as well as weight and appetite loss. A second hematologic malignancy, a stage IIIb multiple myeloma, was diagnosed. Treatment with a scheme of the elderly was carried out, based on the careful use of steroids, melphalan and bisphosphonates. Despite the delicate nature of the case, the patient had a 26-month survival after the second diagnosis.Downloads
References
Moreno-Laguard Y, Laguna-Salvia L, Larquin-Comet JI León-Ramentol CC, Hernandez-Soler YF, González-Basulto MJ. Criterios diagnósticos y nuevas opciones terapéuticas para los pacientes con diagnóstico de linfoma no Hodgkin. AMC [revista en internet]. 2019, jun [citado 4 de abril 2022]; 23(3): 415-426. Disponible en: http://revistaamc.sld.cu/index.php/amc/article/view/6340.
Martínez López A. Mutación myd88 l265p en linfomas de de la zona marginal [tesis]. Madrid, España: Universidad autónoma de Madrid; 2019 [citado 22 de agosto de 2022]. Disponible en: https://repositorio.uam.es/bitstream/handle/10486/690424/martinez_lopez_azahara.pdf?sequence=1.
Leucemia, linfoma y mieloma: qué son, en qué se diferencian y cuáles son sus síntomas y tratamientos. CAEME [en línea]. c2021 [actualizado 29 septiembre, 2020; citado 22 de agosto de 2022]. Disponible en: https://www.caeme.org.ar/leucemia-linfoma-y-mieloma-que-son-en-que-se-diferencian-y-cuales-son-sus-sintomas-y-tratamientos/.
Serra-Valdés M, Alfaro-Amigó A, Viera-García M. Síndrome de hiperviscosidad como presentación del mieloma múltiple. Reporte un de caso. Revista Finlay [revista en internet]. 2013 [citado 22 de agosto 2022]; 3(1). Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/186.
Sociedad Argentima de Hematología. Guías de Diagnóstico y tratamiento de Hematología. Argentina: Sociedad Argentima de Hematología; 2019.
Roja Díaz-García JD, Parra-Landázury NM, Fuentes-Venegas A. Linfoma maligno enmascarado como mieloma múltiple. Actual. Med. [revista en internet]. 2017 [citado 22 de agosto 2022]; 102(802): 173-175 Disponible en: http://dx.doi.org/10.15568/am.2017.802.cc02.
Chen H, Guimin Z, Lianjing W, Huichao Z, Xiaolin W. Simultaneous occurrence of Hodgkin's lymphoma and multiple myeloma: A case report and review of the literature. Oncol. Lett. [revista en internet]. 2016 [citado 22 de agosto 2022]; 11(6): 4139-4143. Disponible en: https://doi.org/10.3892/ol.2016.4503.
Downloads
Published
How to Cite
Issue
Section
License
This journal provides free and immediate access to its content under the principle that making research freely available to the public supports a greater exchange of global knowledge. This means that the authors transfer the copyright to the journal, so that copies and distribution of the contents can be made by any means, as long as the authors' acknowledgment is maintained. These terms are a reflection that the journal assumes copyright under Creative Commons licenses, specifically under a Creative Commons Attribution 4.0 International license.
Registration and submission of articles to the journal is free. The processing, including review, editing and publication, is completely free of charge.
